SINGAPORE (Oct 2): Glove maker Riverstone Holdings is in good position to face rising healthcare competition, says Maybank Kim Eng in an Oct 1 note. The research house is maintaining its “buy” rating with an unchanged target price of $2.12.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply